Evidence map›Paper›PMID 31182757›Full record

ArticleScientific reports2019

Whole-blood transcriptomic signatures induced during immunization by chloroquine prophylaxis and Plasmodium falciparum sporozoites.

Tuan M Tran, Else M Bijker, Mariëlle C Haks, Tom H M Ottenhoff, Leo Visser, Remko Schats, Pratap Venepally, Hernan Lorenzi, Peter D Crompton, Robert W Sauerwein

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The host targeting effect of chloroquine in malaria.Current opinion in immunology · 2020
    Review
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Tuan M TranDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-1928-861X
Else M BijkerDepartment of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Mariëlle C HaksDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Tom H M OttenhoffDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Leo VisserDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Remko SchatsDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Pratap VenepallyDepartment of Infectious Diseases, J. Craig Venter Institute, Rockville, Maryland, USA.
Hernan LorenziDepartment of Infectious Diseases, J. Craig Venter Institute, Rockville, Maryland, USA.ORCID http://orcid.org/0000-0003-0910-7894
Peter D CromptonLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA. pcrompton@niaid.nih.gov.
Robert W SauerweinDepartment of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands. robert.sauerwein@radboudumc.nl.
Leiden University Medical Center · NLJ. Craig Venter Institute · USRadboud University Nijmegen · NLIndiana University School of MedicineNational Institutes of Health · US

Funding

The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI FOUTS, DERRICK · 2014 to 2018
$29.7M
Defining clinical and sterile immunity to Plasmodium falciparum infection using systems biology approachesK08AI125682 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI TRAN, TUAN MANH · 2017 to 2021
$926k
NIAID NIH HHS K08 AI125682NIAID NIH HHS U19 AI110819
6 · The paper itself

Abstract

A highly effective vaccine that confers sterile protection to malaria is urgently needed. Immunization under chemoprophylaxis with sporozoites (CPS) consistently confers high levels of protection in the Controlled Human Malaria infection (CHMI) model. To provide a broad, unbiased assessment of the composition and kinetics of direct ex vivo human immune responses to CPS, we profiled whole-blood transcriptomes by RNA-seq before and during CPS immunization and following CHMI challenge. Differential expression of genes enriched in modules related to T cells, NK cells, protein synthesis, and mitochondrial processes were detected in fully protected individuals four weeks after the first immunization. Non-protected individuals demonstrated transcriptomic changes after the third immunization and the day of treatment, with upregulation of interferon and innate inflammatory genes and downregulation of B-cell signatures. Protected individuals demonstrated more significant interactions between blood transcription modules compared to non-protected individuals several weeks after the second and third immunizations. These data provide insight into the molecular and cellular basis of CPS-induced immune protection from P. falciparum infection.

Indexed as

AnimalsAntimalarialsB-LymphocytesChemopreventionChloroquineHumansMalaria, FalciparumMalaria VaccinesPlasmodium falciparumSporozoitesTranscriptomeVaccinationAntimalarialsChloroquineMalaria Vaccines

Identifiers

PMID31182757
PMCPMC6557840
OpenAlexW2948974170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.